je.st
news
Tag: with
A senior Morrisons employee from Harrogate has been charged with insider dealing.
2014-09-29 17:50:22| Grocery - Topix.net
Paul Coyle, who lives in the town and has been on the board of trustees for Saint Michael's Hospice, is a former group treasurer and head of tax at the Bradford-based supermarket. He was held last December at his home in Harrogate, as part of an investigation by the Financial Conduct Authority .
Tags: with
senior
employee
charged
Merck Announces First Presentation of Early Data on the Investigational Use of KEYTRUDA (pembrolizumab) in Patients with Advanced Bladder Cancer at ESMO 2014
2014-09-29 11:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. KEYTRUDA monotherapy achieved 24 percent overall response rate in patients with PD-L1 positive, advanced bladder (urothelial) cancer Planned Phase 3 study in advanced bladder cancer to be initiated by the end of 2014 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data on the investigational use of KEYTRUDA (pembrolizumab) the companys anti-PD-1 therapy in PD-L1 positive, advanced urothelial cancer (also known as bladder cancer). Language: English Contact: MerckMedia:Ian McConnell, 973-901-5722Claire Mulhearn, 908-423-7425orInvestor:Joseph Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
data
advanced
early
MAN shows TGX parallel diesel hybrid truck concept, previews CNG in TGM trucks at IAA; gearbox cooperation with Scania
2014-09-28 14:36:12| Green Car Congress
In son's memory, a businessman helps others with interest-free loans
2014-09-28 14:31:19| Automakers - Topix.net
At 78, Jordan Berman has navigated through life quite comfortably, professionally speaking, rising from office boy at a North Philadelphia auto-parts distributor to president of the company. Since his retirement 22 years ago, the Blue Bell resident has been an entrepreneurial "dabbler," the last seven years with his grandchildren in a range of pursuits, including auto parts, illustrated art, construction, health food, and fashion T-shirts.
MSD Announces First Presentation of Data on the Investigational Use of Pembrolizumab in Patients with Advanced Gastric Cancer at ESMO 2014
2014-09-28 09:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Pembrolizumab monotherapy achieved 31 percent overall response rate in patients with PD-L1 positive, advanced gastric cancer Phase 2 study to be initiated in first quarter of 2015 (KEYNOTE-059) WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MSD, known as Merck in the United States and Canada, today announced the first presentation of data on the investigational use of pembrolizumab the companys anti-PD-1 therapy in PD-L1 positive, advanced gastric cancer. The early findings presented showed an overall response rate (confirmed and unconfirmed) of 31 percent with pembrolizumab as monotherapy, as measured by investigator assessed, RECIST v1.1 (n= 12/39: 95% CI, 17-47). Language: English Contact: For MSDMedia:Ian McConnell, 973-901-5722orClaire Mulhearn, 908-423-7425orInvestors:Joseph Romanelli, 908-423-5185orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
data
advanced
presentation
Sites : [589] [590] [591] [592] [593] [594] [595] [596] [597] [598] [599] [600] [601] [602] [603] [604] [605] [606] [607] [608] next »